000			01921 a2200517 4500
005			20250517022921.0
264		0	_c20160418
008			201604s 0 0 eng d
022			_a1873-7544
024	7		_a10.1016/j.neuroscience.2015.03.021 _2doi
040			_aNLM _beng _cNLM
100	1		_aSu, S-H
245	0	0	_aCannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling. _h[electronic resource]
260			_bNeuroscience _cAug 2015
300			_a563-75 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBenzamides _xtherapeutic use
650	0	4	_aBenzoxazines _xtherapeutic use
650	0	4	_aCalcium Channel Blockers _xtherapeutic use
650	0	4	_aCarbamates _xtherapeutic use
650	0	4	_aCarotid Stenosis _xdrug therapy
650	0	4	_aCerebral Cortex _xpathology
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Interactions
650	0	4	_aEnzyme Inhibitors _xtherapeutic use
650	0	4	_aJNK Mitogen-Activated Protein Kinases _xmetabolism
650	0	4	_aMale
650	0	4	_aMaze Learning _xdrug effects
650	0	4	_aMorpholines _xtherapeutic use
650	0	4	_aNaphthalenes _xtherapeutic use
650	0	4	_aNeurons _xdrug effects
650	0	4	_aPhosphopyruvate Hydratase _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTime Factors
700	1		_aWu, Y-F
700	1		_aLin, Q
700	1		_aYu, F
700	1		_aHai, J
773	0		_tNeuroscience _gvol. 301 _gp. 563-75
856	4	0	_uhttps://doi.org/10.1016/j.neuroscience.2015.03.021 _zAvailable from publisher's website
999			_c24729296 _d24729296